The Plastic Surgeon's Verdict: Gender Surgery Is Mutilation, Not Medicine - Dr.Patrick Lappert (#30)
18 August 2025
With Dr. Patrick Lappert
youth-gender-medicine
A veteran plastic surgeon turns the tools of his own specialty against what he calls its greatest ethical failure. Dr. Patrick Lappert argues that gender surgery has bypassed the foundational rules of reconstructive medicine—operating on patients whose distress originates in psychiatric disorder, and doing so on the basis of the weakest available evidence while claiming clinical authority. The episode examines what happens when professional bodies elevate an ideological consensus to the status of standard of care, and what it costs the patients—especially the young ones—who bear the consequences.
Medicine earns public trust by subordinating enthusiasm to evidence. When an entire field drifts from that foundation, the consequences fall on the most vulnerable. Dr. Patrick Lappert, a board-certified plastic and reconstructive surgeon with more than forty years of experience—including military training and long civilian practice—has spent years examining the gap between what gender surgery promises and what it delivers. In this episode he sets out, with considerable clinical precision, why he believes his own specialty has failed its patients and violated its own ethical foundations. His central charge concerns evidence. The procedures grouped under gender-affirming care operate, by his account, on Level 5 evidence—the lowest tier of clinical research, equivalent to expert opinion alone. Yet the same body of practice has been designated a standard of care by professional organisations whose authority rests on the assumption of rigorous science. That phrase carries enormous institutional weight: it shapes hospital policy, silences dissenting clinicians, and is cited in courtrooms. When the underlying evidence does not support the designation, the label functions as ideology rather than medicine. Lappert adds a second layer of ethical failure drawn from within his own specialty. Plastic surgeons are professionally forbidden from operating on patients whose distress originates in body dysmorphic disorder, because surgery reliably fails to resolve the underlying psychiatric condition. His argument is that gender dysphoria in young patients—particularly within a broader context of anxiety and obsessive thinking—shares enough of that diagnostic profile to trigger the same prohibition. The field, he contends, has reclassified the condition to sidestep the ethical constraint it would otherwise impose. The episode does not avoid surgical specifics. Lappert describes the functional limitations of phalloplasty, serious complications following vaginoplasty, and the permanent severing of a nerve pathway associated with maternal bonding after chest masculinisation. These are predictable outcomes, he argues, that are routinely underweighted in the consent process. Young patients lack the developmental capacity to imagine a future shaped by consequences they cannot yet grasp. This failure of informed consent is not incidental—it is structural, and the institutions that set the standards bear responsibility for it. What the episode ultimately illuminates is how thoroughly a cultural idea can reorganise professional practice once it gains institutional momentum. Gender identity ideology did not simply influence medicine from outside; it restructured internal standards of evidence, redrew ethical boundaries, and redefined who qualifies as a credible witness to harm. The account of surgeons beginning to step away from these procedures suggests the consensus is under strain—not because the ideology has softened, but because the accumulating evidence of harm is becoming harder for individual practitioners to ignore.
